Activity of pyrazinamide in the guinea pig model of tuberculosis.

Denis A Mitchison
Author Information

Abstract

No abstract text available.

References

  1. Int J Tuberc Lung Dis. 2006 Mar;10(3):317-22 [PMID: 16562713]
  2. Semin Respir Crit Care Med. 2004 Jun;25(3):307-15 [PMID: 16088472]
  3. J Chemother. 2006 Dec;18(6):617-23 [PMID: 17267339]
  4. Lancet. 1972 May 20;1(7760):1079-85 [PMID: 4112569]
  5. Antimicrob Agents Chemother. 2009 Aug;53(8):3197-204 [PMID: 19451303]
  6. Ann Inst Pasteur (Paris). 1958 Jun;94(6):694-708 [PMID: 13534070]
  7. Antimicrob Agents Chemother. 2010 May;54(5):1820-33 [PMID: 20160055]
  8. Am Rev Tuberc. 1954 Aug;70(2):367-9 [PMID: 13180876]
  9. Am J Respir Crit Care Med. 2003 May 15;167(10):1348-54 [PMID: 12519740]

MeSH Term

Animals
Antitubercular Agents
CD8-Positive T-Lymphocytes
Disease Models, Animal
Drug Therapy, Combination
Female
Forkhead Transcription Factors
Guinea Pigs
Interleukin-10
Leukocyte Common Antigens
Pyrazinamide
Tuberculosis, Pulmonary

Chemicals

Antitubercular Agents
Forkhead Transcription Factors
Interleukin-10
Pyrazinamide
Leukocyte Common Antigens